UTI Asset Management Company Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
UTIAMC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts less than Nifty Smallcap 250 and 3.1 pts less than its Asset Management Company peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
UTI AMC reported its unaudited financial results for the quarter ended June 30, 2025. Standalone total income rose to Rs 438.31 crore from Rs 390.01 crore in the year-ago quarter, while standalone profit after tax grew to Rs 216.13 crore from Rs 185.81 crore. Standalone EPS stood at Rs 16.88. On a consolidated basis, PAT was Rs 253.86 crore versus Rs 274.30 crore in Q1 FY25, with EPS of Rs 18.50. The Board also approved an unsecured working capital loan of Rs 45 crore to its wholly owned subsidiary UTI Alternatives Private Limited, repayable by March 31, 2028 at the 1-year SBI MCLR rate.
Standalone earnings show healthy growth driven by higher fee income and fair value gains, but a dip in consolidated profit indicates pressure at the group level. The Rs 45 crore inter-corporate loan to a wholly owned subsidiary is a routine related-party transaction at arm's length and unlikely to materially impact shareholders, though it ties up capital that could have been distributed as dividend.